INTEG PLANNING THIRD QUARTER 510(K) FOR "PAINLESS AND BLOODLESS" GLUCOSE SENSOR; 300-PATIENT STUDY PLANNED FOR MAY, AND U.S. ROLL-OUT SLATED FOR 1997
This article was originally published in The Gray Sheet
Executive Summary
Integ is planning a consumer study to support a 510(k) for its "painless and bloodless" glucose sensor that the company expects to file in the third quarter of 1996.